Round table: “The ecosystem of trust in nuclear medicine: Achieving technological leadership through the convergence of business, academia, education, and government”
Technological leadership is one of Russia’s key national priorities, shaping its competitiveness and influence on the global stage. Achieving this status requires a systematic approach across the entire spectrum, from fundamental research to the deployment of breakthrough solutions in the real economy. In this context, nuclear medicine occupies a special position – it is an area in which Russia has traditionally had robust capabilities, while its potential for a breakthrough is considered high. The country ranks among the global leaders in nuclear technology and the production of radionuclides in demand for healthcare.
However, consolidating and strengthening these positions requires more than a strong technological base. It is critical to build an ecosystem of trust between regulators, radiopharmaceutical manufacturers, medical centres and educational institutions in partner countries. Trust is the core pre-condition for multicentre clinical trials, the harmonisation of quality standards, mutual recognition of test results, and the safe circulation of radiopharmaceutical medicinal products.
The key factors in achieving technological leadership within nuclear medicine are the advanced development of technologies and training highly qualified professionals. Failing to secure specialists equipped with core competencies in nuclear medicine, physics, radiobiology, radiochemistry, and clinical dosimetry makes it impossible to guarantee sovereignty within critical medical technologies. This necessitates a systemic overhaul of approaches to medical education – spanning from fundamental training to practice-oriented pathways tailored to the needs of national healthcare systems.
The Russian educational system traditionally attracts international interest owing to its foundational character, academic depth, and a diverse portfolio of curricula. Training international students at Russian universities fosters a long-term commitment to domestic technological and clinical frameworks. This, in turn, establishes the groundwork for expanding export potential, developing medical tourism, and building collaborative supply chains.
Systematic government support measures play an important role in this process, including the harmonisation of the classification of medical specialties, mutual recognition of qualifications based on intergovernmental agreements, and initiatives by universities, public organisations and diplomatic missions to promote Russian education and culture. Coordinated efforts by all stakeholders will not only expand the international reach of Russian programmes but also strengthen Russia’s image as a reliable partner in science, education and high-tech medicine.
How can Russia’s reputation as a leading nation in the field of nuclear medicine be strengthened? Which measures are required to promote Russian technologies and education within the nuclear medicine sector across the CIS and BRICS+ countries? How can international medical tourism within the nuclear medicine field be developed? These and other questions will be addressed by the discussion participants.